E-LIB Suche - Ergebnisse für: Fraser-Pitt, Douglas J.

1

Cysteamine-mediated blockade of the glycine cleavage system..:

Fraser-Pitt, Douglas ; Mercer, Derry K. ; Francis, Marie-Louise...
Biochemical and Biophysical Research Communications. 677 (2023) - p. 168-181 , 2023

Link: https://doi.org/10.1016/..

2

Cysteamine Inhibits Glycine Utilisation and Disrupts Virule..:

Fraser-Pitt, Douglas J. ; Dolan, Stephen K. ; Toledo-Aparicio, David...
Frontiers in Cellular and Infection Microbiology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

3

Oral cysteamine as an adjunct treatment in cystic fibrosis ..:

Devereux, Graham ; Wrolstad, Danielle ; Bourke, Stephen J....
PLOS ONE. 15 (2020) 12 - p. e0242945 , 2020

Link: https://doi.org/10.1371/..

4

Rapid and robust analytical protocol for E. coli STEC bacte..:

Mclean, Kevin ; Palarea-Albaladejo, Javier ; Currie, Carol G....
Talanta. 182 (2018) - p. 164-170 , 2018

Link: https://doi.org/10.1016/..

5

Cysteamine, an Endogenous Aminothiol, and Cystamine, the Di..:

Fraser-Pitt, Douglas J. ; Mercer, Derry K. ; Smith, Daniel...
Infection and Immunity. 86 (2018) 6 - p. , 2018

Link: https://doi.org/10.1128/..

6

An Open-Label Investigation of the Pharmacokinetics and Tol..:

Devereux, Graham ; Steele, Sandra ; Griffiths, Kairen...
Clinical Drug Investigation. 36 (2016) 8 - p. 605-612 , 2016

Link: https://doi.org/10.1007/..

7

Activity of Cysteamine against the Cystic Fibrosis Pathogen..:

Fraser-Pitt, Douglas ; Mercer, Derry ; Lovie, Emma..
Antimicrobial Agents and Chemotherapy. 60 (2016) 10 - p. 6200-6206 , 2016

Link: https://doi.org/10.1128/..

8

Cystic Fibrosis – a Multiorgan Protein Misfolding Disease:

Fraser-Pitt, Douglas ; O'Neil, Deborah
Future Science OA. 1 (2015) 2 - p. , 2015

Link: https://doi.org/10.4155/..

9

Cysteamine as a Future Intervention in Cystic Fibrosis Agai..:

Devereux, Graham ; Fraser-Pitt, Douglas ; Robertson, Jennifer...
EBioMedicine. 2 (2015) 10 - p. 1507-1512 , 2015

Link: https://doi.org/10.1016/..

10

Cysteamine (Lynovex®), a novel mucoactive antimicrobial & a..:

Charrier, Cedric ; Rodger, Catherine ; Robertson, Jennifer...
Orphanet Journal of Rare Diseases. 9 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

11

Phosphorylation of the epidermal growth factor receptor (EG..:

Fraser-Pitt, Douglas J. ; Cameron, Pamela ; McNeilly, Tom N....
Microbiology. 157 (2011) 8 - p. 2339-2347 , 2011

Link: https://doi.org/10.1099/..

12

Analysis of the expression, regulation and export of NleA–E..:

Roe, Andrew J ; Tysall, Luke ; Dransfield, Tracy...
Microbiology. 153 (2007) 5 - p. 1350-1360 , 2007

Link: https://doi.org/10.1099/..

13

Cysteamine inhibits glycine utilisation and disrupts virule..:

Fraser-Pitt, Douglas J ; Dolan, Stephen K ; Toledo-Aparicio, David...
https://rgu-repository.worktribe.com/output/1500305. , 2021

Link: https://doi.org/10.3389/..

14

CARE-CF-1 Clinical trial data: An exploratory, randomized, ..:

Fraser-Pitt, Douglas
https://zenodo.org/communities/dryad. , 2020

Link: https://zenodo.org/recor..

15

Oral cysteamine as an adjunct treatment in cystic fibrosis ..:

Devereux, Graham ; Wrolstad, Danielle ; Bourke, Stephen J...
https://archive.lstmed.ac.uk/16560/1/Graham%20Deveruex%20-%20Oral%20cysteamine%20as%20an%20adjunct%20treatment%20in%20cystic%20fibrosis%20pulmonary%20exacerbations.docx. , 2020

Link: https://archive.lstmed.a..